SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0000950170-22-002557
Filing Date
2022-03-01
Accepted
2022-03-01 16:31:07
Documents
1
Period of Report
2021-12-31
Effectiveness Date
2022-03-01

Document Format Files

Seq Description Document Type Size
1 NT 10-K srne_form_12b-25.htm NT 10-K 27654
  Complete submission text file 0000950170-22-002557.txt   28787
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-36150 | Film No.: 22698639
SIC: 2836 Biological Products, (No Diagnostic Substances)